Novartis Ag (NVS) Short-term Investments (2009 - 2026)
Novartis Ag (NVS) posted Short-term Investments of $2.3 billion for Q2 2026, up 11.3% from $2.07 billion a year earlier but down 1.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Short-term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag's Short-term Investments came in at $2.35 billion, up 16.5% from FY2024.
- Annual Short-term Investments shows a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
- In prior years, Novartis Ag's Short-term Investments was $2.02 billion in FY2024 (-22.7%), $2.61 billion in FY2023 (+8.1%), $2.41 billion in FY2022 (-84.9%) and $15.92 billion in FY2021 (+448.8%).
- Quarterly Short-term Investments has run from a low of $1.92 billion in Q3 2023 to a high of $15.92 billion in Q4 2021 over five years.
- On a year-over-year basis, Short-term Investments has increased in each of the last three quarters, with growth averaging 1.6% over the last eight quarters.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q4 2021, with growth of 448.8%; the weakest was Q4 2022, with a decline of 84.9%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $2.33 billion (Q1 2026), $2.35 billion (Q4 2025) and $2.07 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 155.00 Mn |
| Sep 30, 2025 | 197.00 Mn |
| Jun 30, 2025 | 344.00 Mn |
| Mar 31, 2025 | 130.00 Mn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 411.00 Mn |
| Jun 30, 2024 | 532.00 Mn |
| Mar 31, 2024 | 225.00 Mn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 290.00 Mn |
| Jun 30, 2023 | 289.00 Mn |
| Mar 31, 2023 | 260.00 Mn |
| Dec 31, 2022 | 11.41 Bn |
| Sep 30, 2022 | 10.38 Bn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 4.96 Bn |
| Dec 31, 2021 | 15.92 Bn |
| Sep 30, 2021 | 951.00 Mn |
API Access
Novartis Ag Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();